REQUEST A DEMO
Total
USD $0.00
Search more companies

STEROGENE EUROPE Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: STEROGENE EUROPE Szolgaltato Kft. Profile Updated: August 31, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

sterogene bioseparations, inc is a biotechnology company. The company specializes in the development of chromatography resins for downstream processes. sterogene bioseparations, inc offers solutions for the purification of immunoglobulins from various species. The company claims to target markets in South East Asia and operates in the biotechnology and pharmaceuticals industry.

Headquarters
Szabadsag utca 2.
Ujronafo; Gyor-Moson-Sopron; Postal Code: 9244

Contact Details: Purchase the STEROGENE EUROPE Kft. report to view the information.

Website: http://www.sterogene.com

Basic Information
Total Employees:
Purchase the STEROGENE EUROPE Kft. report to view the information.
Outstanding Shares:
Purchase the STEROGENE EUROPE Kft. report to view the information.
Registered Capital:
Purchase the STEROGENE EUROPE Kft. report to view the information.
Incorporation Date:
July 31, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after STEROGENE EUROPE Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-61.56%
Total operating revenue
-55.79%
Operating profit (EBIT)
342.12%
EBITDA
277.71%
Net Profit (Loss) for the Period
305.35%
Total assets
-3.44%
Total equity
57.82%
Operating Profit Margin (ROS)
72.92%
Net Profit Margin
77.2%
Return on Equity (ROE)
22.38%
Quick Ratio
399.56%
Cash Ratio
7.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?